Completed PHASE2 INTERVENTIONAL 2-arm NCT02010242

Safety and Efficacy of Oral GKT137831 in Patient With Type 2 Diabetes and Albuminuria

A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Study Evaluating the Safety and Efficacy of Oral GKT137831 in Patients With Type 2 Diabetes and Albuminuria

Sponsor: Calliditas Therapeutics AB

Conditions Type 2 Diabetes Mellitus With Diabetic Nephropathy

Interventions GKT137831 Placebo

Updated 11 times since 2017 Last updated: Feb 7, 2025 Started: Oct 31, 2013 Primary completion: Feb 28, 2015 Completion: Mar 31, 2015

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT02010242, this PHASE2 trial focuses on Type 2 Diabetes Mellitus With Diabetic Nephropathy and remains completed. Sponsored by Calliditas Therapeutics AB, it has been updated 11 times since 2013, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

11 versions recorded

Oct 2025 — Present [monthly]

Completed PHASE2
Sep 2025 — Oct 2025 [monthly]

Completed PHASE2
Mar 2025 — Sep 2025 [monthly]

Completed PHASE2
Sep 2024 — Mar 2025 [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2

▶ Show 6 earlier versions

Jul 2022 — Jul 2024 [monthly]

Completed PHASE2
May 2022 — Jul 2022 [monthly]

Completed PHASE2
Jan 2021 — May 2022 [monthly]

Completed PHASE2
Jun 2018 — Jan 2021 [monthly]

Completed PHASE2
Feb 2017 — Jun 2018 [monthly]

Completed PHASE2
Jan 2017 — Feb 2017 [monthly]

Completed PHASE2

First recorded

Oct 2013

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Calliditas Therapeutics AB

Data source: Calliditas Therapeutics AB

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Aschaffenburg, Germany , Brampton, Canada , Camperdown, Australia , Chattanooga, United States , Chicago, United States , Coral Gables, United States , Dallas, United States , Dayton, United States , Elsterwerda, Germany , Gdansk, Poland and 36 more locations